911 results on '"Long, Carole A."'
Search Results
2. Infectivity of Plasmodium parasites to Aedes aegypti and Anopheles stephensi mosquitoes maintained on blood-free meals of SkitoSnack
3. Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
4. Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
5. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
6. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype
7. Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development
8. A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle
9. Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies
10. Structure-based design of a strain transcending AMA1-RON2L malaria vaccine
11. A human antibody epitope map of the malaria vaccine antigen Pfs25
12. Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
13. A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabe adults
14. Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
15. Extending the range of Plasmodium falciparum transmission blocking antibodies
16. A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine
17. Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages
18. Structure of the malaria vaccine candidate Pfs48/45 and its recognition by transmission blocking antibodies
19. Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion
20. Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230
21. Antibody gene features associated with binding and functional activity in malaria vaccine-derived human mAbs.
22. Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with sera from Plasmodium falciparum endemic areas of Africa
23. First Phase 1b, single-center, age de-escalation trial of theP. falciparumblood-stage malaria vaccine candidate RH5.1/Matrix-M™: a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants
24. RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
25. The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation
26. Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
27. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies
28. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
29. Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors
30. NAD activates olfactory receptor 1386 to regulate type I interferon responses in Plasmodium yoelii YM infection.
31. A Self-Assembling Pfs230D1-Ferritin Nanoparticle Vaccine Has Potent and Durable Malaria Transmission-Reducing Activity.
32. A randomized first-in-human Phase 1 trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
33. Evaluation of Precision of thePlasmodium knowlesiGrowth Inhibition Assay forPlasmodium vivaxDuffy-Binding Protein-based Malaria Vaccine Development
34. Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
35. Mesenchymal stem cells of the bone marrow raise infectivity of Plasmodium falciparum gametocytes
36. OA-344 Clinical development in Burkina Faso of novel malaria vaccines based on the Pfs48/45 antigen
37. Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model
38. Genome sequence, transcriptome, and annotation of rodent malaria parasite Plasmodium yoelii nigeriensis N67
39. Autoantibodies inhibit Plasmodium falciparum growth and are associated with protection from clinical malaria
40. Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.
41. Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
42. Dysfunction of CD169 + macrophages and blockage of erythrocyte maturation as a mechanism of anemia in Plasmodium yoelii infection
43. Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
44. Mesenchymal stem cells of the bone marrow raise infectivity ofPlasmodium falciparumgametocytes
45. Antibody gene features associated with binding and functional activity in vaccine-derived human mAbs targeting malaria parasites
46. Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
47. A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
48. Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment
49. Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
50. Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.